Skip to main content

Cour Pharmaceuticals Development

Skokie, United States

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

$105.0M raised
Jan 2024
Series A

Top Investors

Alpha Wave GlobalBristol-Myers SquibbLumira VenturesAngelini VenturesAlpha Wave Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cour Pharmaceuticals Development

How much funding has Cour Pharmaceuticals Development raised?
Cour Pharmaceuticals Development has raised $105.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
Who are Cour Pharmaceuticals Development's investors?
Cour Pharmaceuticals Development's investors include Alpha Wave Global, Bristol-Myers Squibb, Lumira Ventures, Angelini Ventures, Alpha Wave Ventures.
Where is Cour Pharmaceuticals Development headquartered?
Cour Pharmaceuticals Development is headquartered in Skokie, United States.
What does Cour Pharmaceuticals Development do?
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
What stage is Cour Pharmaceuticals Development at?
Cour Pharmaceuticals Development is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cour Pharmaceuticals Development — Funding & Investors." VCBacked, January 30, 2024, https://www.vcbacked.co/company/cour-pharmaceuticals-development. Accessed June 17, 2026.
APA
VCBacked. (2024). Cour Pharmaceuticals Development — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/cour-pharmaceuticals-development
Wikipedia (cite web)
{{cite web |title=Cour Pharmaceuticals Development — Funding & Investors |url=https://www.vcbacked.co/company/cour-pharmaceuticals-development |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .